Try M - Search Results

1

Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measures.

Corbaux P, Bainaud M, Rousseau A, Try M, Saillant A, Lafargue MC, Stocker N, Afchain P, Jamelot M, Isnard-Bagnis C, Campedel L, Delaye M. Corbaux P, et al. Among authors: try m. Support Care Cancer. 2024 Nov 1;32(11):763. doi: 10.1007/s00520-024-08956-8. Support Care Cancer. 2024. PMID: 39482406

2

Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.

Sablik M, Sannier A, Raynaud M, Goutaudier V, Divard G, Astor BC, Weng P, Smith J, Garro R, Warady BA, Zahr RS, Twombley K, Dharnidharka VR, Dandamudi RS, Fila M, Huang E, Sellier-Leclerc AL, Tönshoff B, Rabant M, Verine J, Del Bello A, Berney T, Boyer O, Catar RA, Danger R, Giral M, Yoo D, Girardin FR, Alsadi A, Gourraud PA, Morelon E, Le Quintrec M, Try M, Villard J, Zhong W, Bestard O, Budde K, Chauveau B, Couzi L, Brouard S, Hogan J, Legendre C, Anglicheau D, Aubert O, Kamar N, Lefaucheur C, Loupy A. Sablik M, et al. Among authors: try m. N Engl J Med. 2024 Oct 24. doi: 10.1056/NEJMoa2408835. Online ahead of print. N Engl J Med. 2024. PMID: 39450752

3

Low exposition to lithium prevents nephrogenic diabetes insipidus but not microcystic dilations of the collecting ducts in long-term rat model.

Tabibzadeh N, Klein M, Try M, Poupon J, Houillier P, Klein C, Cheval L, Crambert G, Lasaad S, Chevillard L, Megarbane B. Tabibzadeh N, et al. Among authors: try m. Arch Pharm (Weinheim). 2024 Aug;357(8):e2400063. doi: 10.1002/ardp.202400063. Epub 2024 May 5. Arch Pharm (Weinheim). 2024. PMID: 38704748

4

[Nephroprotection: General principles and application to the patients with cancers - when nephroprotection is essential for oncological care plan].

Bainaud M, Try M, Zaidan M. Bainaud M, et al. Among authors: try m. Bull Cancer. 2024 Jul-Aug;111(7-8):675-686. doi: 10.1016/j.bulcan.2023.05.011. Epub 2023 Oct 10. Bull Cancer. 2024. PMID: 37827963 Review. French.

5

[Electrolyte disorders in oncological patients].

Saillant A, Try M, Laparra A, Lecoq AL, Zaidan M. Saillant A, et al. Among authors: try m. Bull Cancer. 2024 Jul-Aug;111(7-8):687-700. doi: 10.1016/j.bulcan.2023.04.014. Epub 2023 May 17. Bull Cancer. 2024. PMID: 37208250 Review. French.

6

[Renal failure in multiple myeloma: Specific management issues].

Try M, Harel S. Try M, et al. Bull Cancer. 2024 Jul-Aug;111(7-8):733-740. doi: 10.1016/j.bulcan.2022.12.015. Epub 2023 Feb 8. Bull Cancer. 2024. PMID: 36759215 French.

7

Discussion on methadone initiation protocols: A case report.

Delaye M, Laurent S, Try M, Treillet E. Delaye M, et al. Among authors: try m. J Opioid Manag. 2022 Sep-Oct;18(5):487-491. doi: 10.5055/jom.2022.0742. J Opioid Manag. 2022. PMID: 36226788

8

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer.

Delaye M, Rousseau A, Try M, Massard C, Campedel L, Hilmi M, Bagnis C. Delaye M, et al. Among authors: try m. Cancer Med. 2023 Feb;12(3):3172-3175. doi: 10.1002/cam4.5171. Epub 2022 Sep 26. Cancer Med. 2023. PMID: 36156460 Free PMC article. Clinical Trial.

9

Onco-nephrology: Physicians' Expectations About a New Subspecialty.

Delaye M, Try M, Rousseau A, Lafargue MC, Saillant A, Bainaud M, Andreani M, Rozenblat D, Campedel L, Corbaux P, Isnard-Bagnis C. Delaye M, et al. Among authors: try m. J Cancer Educ. 2023 Jun;38(3):878-884. doi: 10.1007/s13187-022-02201-8. Epub 2022 Jul 15. J Cancer Educ. 2023. PMID: 35840858

10

[Targeted therapies and high blood pressure].

Try M, Cohen A, Ederhy S. Try M, et al. Rev Prat. 2021 Feb;71(2):212-215. Rev Prat. 2021. PMID: 34160986 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters